Expect More Use of the Antibiotics Avycaz or Vabomere for "CRE"
October 2018
You'll hear continued debate about which antibiotics to use to treat carbapenem-resistant Enterobacteriaceae (CRE) infections.
Work with ID to tailor regimens based on susceptibility and safety.
Newer antibiotics. Anticipate using ceftazidime/avibactam (Avycaz)or meropenem/vaborbactam (Vabomere) more. Recent evidence suggests they are safer and may be more effective than traditional options...such as meropenem PLUS a polymyxin (colistin, etc).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote